Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Tackling Mantle Cell Lymphoma in Europe

Horgan, Denis ; Walewski, Jan ; Aurer, Igor ; Visco, Carlo ; Giné, Eva ; Fetica, Bogdan ; Jerkeman, Mats LU ; Kozaric, Marta ; da Silva, Maria Gomes and Dreyling, Martin (2022) In Healthcare (Switzerland) 10(9).
Abstract

An expert panel convened by the European Alliance for Personalized Medicine (EAPM) reflected on achievements and outstanding challenges in Europe in mantle cell lymphoma (MCL). Through the prism of member state experience, the panel noted advances in outcomes over the last decade, but highlighted issues constituting barriers to better care. The list notably included availability of newer treatments, infrastructure and funding for related testing, and shortages of relevant skills and of research support. The prospect of improvements was held to reside in closer coordination and cooperation within and between individual countries, and in changes in policy and scale of investment at both national and EU levels.

Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
barriers, care, EU level, healthcare, infrastructure, mantle cell lymphoma, MCL, personalized medicine, policy framework, treatment
in
Healthcare (Switzerland)
volume
10
issue
9
article number
1682
publisher
MDPI AG
external identifiers
  • scopus:85138525990
  • pmid:36141294
ISSN
2227-9032
DOI
10.3390/healthcare10091682
language
English
LU publication?
yes
id
da2339b9-510d-4024-bfd6-2375ccb1de3d
date added to LUP
2022-12-14 10:05:41
date last changed
2024-06-23 16:54:43
@article{da2339b9-510d-4024-bfd6-2375ccb1de3d,
  abstract     = {{<p>An expert panel convened by the European Alliance for Personalized Medicine (EAPM) reflected on achievements and outstanding challenges in Europe in mantle cell lymphoma (MCL). Through the prism of member state experience, the panel noted advances in outcomes over the last decade, but highlighted issues constituting barriers to better care. The list notably included availability of newer treatments, infrastructure and funding for related testing, and shortages of relevant skills and of research support. The prospect of improvements was held to reside in closer coordination and cooperation within and between individual countries, and in changes in policy and scale of investment at both national and EU levels.</p>}},
  author       = {{Horgan, Denis and Walewski, Jan and Aurer, Igor and Visco, Carlo and Giné, Eva and Fetica, Bogdan and Jerkeman, Mats and Kozaric, Marta and da Silva, Maria Gomes and Dreyling, Martin}},
  issn         = {{2227-9032}},
  keywords     = {{barriers; care; EU level; healthcare; infrastructure; mantle cell lymphoma; MCL; personalized medicine; policy framework; treatment}},
  language     = {{eng}},
  number       = {{9}},
  publisher    = {{MDPI AG}},
  series       = {{Healthcare (Switzerland)}},
  title        = {{Tackling Mantle Cell Lymphoma in Europe}},
  url          = {{http://dx.doi.org/10.3390/healthcare10091682}},
  doi          = {{10.3390/healthcare10091682}},
  volume       = {{10}},
  year         = {{2022}},
}